Necrosis of myeloma-infiltrated ileum following cytotoxic chemotherapy
Marks, D.I.; Firkin, F.C.
Australian and New Zealand Journal of Medicine 17(1): 80
1987
ISSN/ISBN: 0004-8291 PMID: 3476053 Document Number: 288494
Document emailed within 1 workday
Related Documents
G.Mead, P.; H.D. Carr-Smith; M.Drayson, T.; A.R. Bradwell 2003: Detection of Bence Jones Myeloma and Monitoring of Myeloma Chemotherapy UsingImmunoassays Specific for Free Immunoglobulin Light Chains Clinical Laboratory 49(1-2): 25-27Meier, L.; Hollinger, A.; Umbricht, R.; Tamborini, P. 1992: Necrosis of the terminal ileum after drug poisoning. Case report Helvetica Chirurgica Acta 59(2): 407-409
Pisa, P.; Stenke, L.; Bernell, P.; Hansson, M.; Hast, R. 1990: Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients Anticancer Research 10(3): 817-820
White, D.R.; Cooper, M.R.; Muss, H.B.; Richards, F.; Spurr, C.L. 1979: Complications of cytotoxic antineoplastic chemotherapy North Carolina Medical Journal 40(2): 73-78
Jantová, S.; Urbancíková, M.; Maliar, T.; Mikulásová, M.; Rauko, P.; Cipák, L.; Kubíková, J.; Stankovský, S.; Spirková, K. 2001: Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton Neoplasma 48(1): 52-60
Robinet, E.; Branellec, D.; Termijtelen, A.M.; Blay, J.Y.; Gay, F.; Chouaib, S. 1990: Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells Journal of Immunology 144(12): 4555-4561
Paule, B.; Quillard, J.; Bisson, M.; Massias, P. 1987: Heterogenicity of the response to chemotherapy in plasmablastic myeloma Nouvelle Revue Francaise d'Hematologie 29(6): 391-396
Sezaki, T. 1989: Current results of chemotherapy in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 1997-2003
Iakupova, E.V.; Grinchuk, O.V.; Kalimullina, D.Kh.; Bakirov, B.A.; Galimova, R.R.; Makarova, O.V.; Khusnutdinova, E.K.; Viktorova, T.V. 2003: Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma Molekuliarnaia Biologiia 37(3): 420-424
Manoharan, A.; Schonell, M. 1980: Radiation pneumonia complicating adjuvant cytotoxic chemotherapy Australian and New Zealand Journal of Medicine 10(2): 218-220
Tribalto, M.; Arcese, W.; Colombo, R.; Pastore, S.; Franchii, A. 1981: Chemotherapy of multiple myeloma. Review of the recent trials Recenti Progressi in Medicina 71(2): 141-147
Raghavan, D.; Pearson, B.; Watt, W.H.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R. 1991: Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens Seminars in Oncology 18(1 Suppl 3): 56-63
Ilveskoski, E.; Nikus, K.; Tanner, M.; Eskola, M. 2009: Coronary artery disease attack caused by cytotoxic chemotherapy Duodecim; Laaketieteellinen Aikakauskirja 125(9): 997-1001
Kasili, E.G. 1976: Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma East African Medical Journal 53(9): 554-559
Alexanian, R.; Migliore, P.J. 1970: Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy Journal of Laboratory and Clinical Medicine 75(2): 225-233
Thomas, P.J.; Daban, A.; Bontoux, D. 1984: Double hemibody irradiation in chemotherapy-resistant multiple myeloma Cancer Treatment Reports 68(9): 1173-1175
Bataille, R.; Morlock, G.; Rosenberg, F.; Sany, J.; Serre, H. 1979: Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(31-32): 1377-1382
Alberts, D.S.; Golde, D.W. 1974: DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy Cancer Research 34(11): 2911-2914
Bataille, R.; Morlock, G.; Sany, J.; Blotman, F.; Simon, L. 1981: Effect of the manner of the response to chemotherapy on the prognosis of myeloma. Preliminary study Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(5): 413-418
Inoue, K.; Yoshiba, M.; Sekiyama, K.; Koh, I.; Fujita, R. 1995: Pathogenic mechanism of fulminant hepatic failure in HBs Ag carrier after withdrawal of cytotoxic chemotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 2): 467-472